Tag: US15687V1098

Certara to Report Second Quarter 2025 Financial Results on August 6th, 2025

RADNOR, Pa., July 09, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that it will release financial results for the second quarter of 2025 after the market close on Wednesday, August 6^th, 2025. Company management will host a conference call to discuss financial results at 5:00PM ET.

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Phone

This field is for validation purposes and should be left unchanged.

HomeTagsUS15687V1098

Earendil Labs announces initiation of a phase 1 study of a half-life extended novel anti-TL1A antibody

SOLAR 2025 Kicks Off Next Month: Review Agenda, Speakers, and Free Public Events

Pixelworks’ Shanghai-based Subsidiary Awarded Local Government Subsidies

Tag: US15687V1098

Certara to Report Second Quarter 2025 Financial Results on August 6th, 2025

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us